Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study

被引:29
作者
Verregghen, Maarten [2 ]
Heijerman, Harry G. [3 ]
Reijers, Monique [4 ]
van Ingen, Jakko [1 ,5 ]
van der Ent, Cornelis K. [6 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Clin Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Univ Utrecht, Fac Med, Utrecht, Netherlands
[3] Haga Hosp, Dept Resp Dis, The Hague, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Dept Resp Dis, NL-6500 HB Nijmegen, Netherlands
[5] Univ Ctr Chron Dis, Nijmegen, Netherlands
[6] Univ Med Ctr Utrecht, Dept Resp Dis, Utrecht, Netherlands
关键词
Cystic fibrosis; Mycobacterium abscessus; Risk factors; Stenotrophomonas maltophilia; Aspergillus fumigatus; NONTUBERCULOUS MYCOBACTERIA; DISEASE; PATHOGENS; LUNG;
D O I
10.1016/j.jcf.2012.01.006
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Mycobacterium abscessus is a nontuberculous mycobacterium that is increasingly recognized as an opportunistic pathogen in cystic fibrosis (CF) patients. Factors that predispose CF patients to infection by this environmental bacterium remain unknown. In a case control study of 22 CF patients with M. abscessus infection and 22 CF controls, we investigated risk factors for MAB infection as well as the positioning of MAB infection in relation to the other pathogens infecting CF patients. No clear risk factors were found; steroid treatment and CF related diabetes were equally common among cases and controls. M. abscessus disease affects CF patients of varying age, lung function and co-morbidities. Antimicrobial maintenance therapy did not prevent M. abscessus infection. A history of Stenotrophomonas maltophilia infection was significantly more frequent among cases than among controls and there may be a relation with Aspergillus fumigatus infection, or both may be signs of advanced lung damage that predisposes to MAB disease. The absence of clear risk factors and the omnipresence of MAB in the environment suggest that MAB infection in CF patients is a random event. Its symptoms and impact on lung function seem to warrant treatment. (c) 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:340 / 343
页数:4
相关论文
共 18 条
  • [1] Nontuberculous mycobacteria in cystic fibrosis
    Ebert, DL
    Olivier, KN
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2002, 16 (01) : 221 - +
  • [2] Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
    Esther, Charles R., Jr.
    Esserman, Denise A.
    Gilligan, Peter
    Kerr, Alan
    Noone, Peadar G.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (02) : 117 - 123
  • [3] An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases
    Griffith, David E.
    Aksamit, Timothy
    Brown-Elliott, Barbara A.
    Catanzaro, Antonino
    Daley, Charles
    Gordin, Fred
    Holland, Steven M.
    Horsburgh, Robert
    Huitt, Gwen
    Iademarco, Michael F.
    Iseman, Michael
    Olivier, Kenneth
    Ruoss, Stephen
    von Reyn, C. Fordham
    Wallace, Richard J., Jr.
    Winthrop, Kevin
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) : 367 - 416
  • [4] Emergence of nontuberculous mycobacteria as pathogens in cystic fibrosis
    Griffith, DE
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 810 - 812
  • [5] Microbial ecology of the cystic fibrosis lung
    Harrison, Freya
    [J]. MICROBIOLOGY-SGM, 2007, 153 : 917 - 923
  • [6] Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
    Jarand, Julie
    Levin, Adrah
    Zhang, Lening
    Huitt, Gwen
    Mitchell, John D.
    Daley, Charles L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (05) : 565 - 571
  • [7] Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis
    Jonsson, Bodil E.
    Gilljam, Marita
    Lindblad, Anders
    Ridell, Malin
    Wold, Agnes E.
    Welinder-Olsson, Christina
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (05) : 1497 - 1504
  • [8] Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy
    Mussaffi, H
    Rivlin, J
    Shalit, I
    Ephros, M
    Blau, H
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (02) : 324 - 328
  • [9] A Novel Gene, erm(41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
    Nash, Kevin A.
    Brown-Elliott, Barbara A.
    Wallace, Richard J., Jr.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) : 1367 - 1376
  • [10] Nontuberculous mycobacteria I: Multicenter prevalence study in cystic fibrosis
    Olivier, KN
    Weber, DJ
    Wallace, RJ
    Faiz, AR
    Lee, JH
    Zhang, YS
    Brown-Elliot, BA
    Handler, A
    Wilson, RW
    Schechter, MS
    Edwards, LJ
    Chakraborti, S
    Knowles, MR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (06) : 828 - 834